Viagra, also known as sildenafil, is generally considered safe for most men with Parkinson's Disease (PD) to use. However, it is important to consult with a healthcare provider before starting any new medication, including Viagra, to ensure it is appropriate for your specific health situation.
In summary, while Viagra is generally safe for individuals with Parkinson's Disease, it is essential to have a healthcare provider evaluate your specific circumstances to ensure it is the right choice for you.
Patient discussions about the use of Viagra and similar medications in the context of Parkinson's disease reveal a range of experiences and considerations.
Patient View
55 still High libido but suffer from ed any thing help better than Ed meds Calais
June 2024 • /r/Parkinsons
Patient View
Hi, I see very little about Parkinsons and sexual health and intimacy in this forum other than how to start a conversation about it with your doctor. I have had two good neurologists and an excellent GP however none have ever asked me about my sex life. I am 73 but not dead yet and think it’s an important topic for discussion. Intimacy is a big part of me feeling good about myself. I am interested to know how people handle rejection and what they find helpful dealing with sexual issues.
March 54063 • living-with-parkinsons
Research has shown that the use of Viagra (sildenafil) in individuals with Parkinson's Disease (PD) is a topic of interest due to its potential effects on cardiovascular health and its interaction with Parkinson's medications. Studies have explored the safety profile of Viagra in this population, focusing on its impact on blood pressure, heart rate, and potential side effects. Here, we summarize the current research findings on this topic.
The use of Viagra in Parkinson's Disease is moderately researched, with a focus on its efficacy in treating erectile dysfunction (ED) and its safety profile. The research includes clinical trials, observational studies, and reviews that assess the impact of Viagra on sexual function and its potential cardiovascular risks in PD patients. While there is a growing body of evidence supporting its use, the topic remains somewhat contentious due to concerns about cardiovascular side effects.
Efficacy and Safety:
Cardiovascular Considerations:
Therapeutic Implications:
Cardiovascular Risks:
Long-term Effects:
Individual Variability:
Research
This study investigated the safety and efficacy of sildenafil (Viagra) in treating erectile dysfunction (ED) in men with Parkinson's Disease (PD). It was a double-blind, placebo-controlled, cross-over study involving 20 men, with sildenafil doses adjusted based on side effects.
The study found that sildenafil significantly improved sexual functioning without affecting PD symptoms or quality of life. Only one instance of headache was reported as a side effect.
For individuals with PD, this study suggests that sildenafil can be a safe option for managing ED, without worsening PD symptoms.
The study's reliability is supported by its double-blind, placebo-controlled design, though the small sample size limits generalizability.
November 2016 • Movement disorders clinical practice
Research
This study explored the effects of sildenafil, a PDE5 inhibitor, in combination with L-DOPA on behavior and neurotransmitter metabolism in a rat model of Parkinson's Disease. The research focused on both acute and chronic administration of sildenafil at different doses.
The findings indicated that sildenafil, particularly at lower doses, modulated dopamine levels and behavior when combined with L-DOPA, suggesting potential benefits in managing Parkinson's symptoms.
For Parkinson's patients, this study implies that sildenafil might influence dopamine metabolism, potentially affecting treatment outcomes when used with L-DOPA.
The study's reliability is supported by its detailed experimental design, though its applicability to humans requires further investigation.
September 2024 • Molecules (Basel, Switzerland)
When considering the use of Viagra for individuals with Parkinson's, it's important to be aware of potential interactions and side effects. Here are some insights from experts:
Blood Pressure Concerns: Viagra is a vasodilator, meaning it can lower blood pressure. This is particularly important for Parkinson's patients, who may already experience low blood pressure due to their condition or medications. Experts advise monitoring blood pressure and possibly having sex lying down to avoid fainting12.
Medication Interactions: While Viagra does not directly interfere with Parkinson's medications, both can lower blood pressure. It's crucial to consider the overall medication regimen and consult with a healthcare provider to ensure safety13.
Consult Healthcare Providers: Experts consistently recommend consulting with healthcare providers before using Viagra to manage erectile dysfunction in Parkinson's patients. This ensures that any potential interactions or side effects are carefully managed34.
Rule Out Other Causes: Erectile dysfunction can be a non-motor symptom of Parkinson's, but it's important to rule out other causes such as peripheral vascular disease or diabetes. Consulting a urologist can help in managing erectile dysfunction effectively45.
Overall, while Viagra can be used by individuals with Parkinson's, it is essential to do so under medical supervision to manage any potential risks effectively.
Video
Dr. Vaughn discusses the interaction between Parkinson's medications and erectile dysfunction drugs like Viagra. He highlights that both can lower blood pressure, which requires careful monitoring. Adjustments may be needed if low blood pressure is a concern, but Viagra does not interfere with Parkinson's medications directly.
February 2020 • The Michael J. Fox Foundation for Parkinson's Research
Video
The video explains that Viagra is a vasodilator, which can lower blood pressure significantly. This effect can be problematic for Parkinson's patients, who may already experience low blood pressure. It is advised to be cautious and possibly have sex lying down to avoid fainting.
March 2022 • Davis Phinney Foundation for Parkinson's
Was this helpful?
This is not healthcare advice or a recommendation. This tool is in beta and currently experimental. It is designed to help you find the most recent and helpful sources, from different voices, for you to take to consider with your healthcare team.
We appreciate any feedback as we aim to help speed up breakthroughs for all conditions.
© 2026 Turnto